NAUJASIS BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 ŠTAMAS IR JO PANAUDOJIMAS VIRŠSVORIO IR NUTUKIMO IR SUSIJUSIŲ LIGŲ GYDYMUI IR (ARBA) PREVENCIJAI
The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and/or pharmaceutical formulations, can be used in the treatment and/or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc.